DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Altace (Ramipril) - Adverse Event Reports - Other Serious Reactions - Dyspnoea

 



Index of reports > Cases resulting in other serious reactions (69) > Cases with Dyspnoea (4)

Below is the selection of adverse event reports related to Altace (Ramipril) that includes cases resulting in other serious reactions where reactions include dyspnoea.

Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from France on 2007-10-22

Patient:

Adverse reactions / side effects: Cryptogenic Organising Pneumonia, Dyspnoea, Eosinophilic Pneumonia, Bronchomalacia, Asthenia, Cough

Adverse event resulted in: hospitalization

Suspect drug(s):
Altace
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Hypertension
    Start date: 2006-11-15
    End date: 2007-01-15

Tenormin
    Dosage: 1 u, qd
    Administration route: Oral
    Start date: 2006-11-15
    End date: 2007-06-13

Kardegic / 00002703 /
    Dosage: 160 mg, qd
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2006-11-15

Tahor
    Dosage: 80 mg, qd
    Administration route: Oral
    Start date: 2006-11-15

Plavix
    Dosage: 75 mg, qd
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2006-11-15
    End date: 2007-01-15



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from France on 2007-07-26

Patient:

Adverse reactions / side effects: LOW Cardiac Output Syndrome, Vomiting, Dyspnoea, Hyperkalaemia, Drug Interaction, Haemodialysis, Cardiac Failure, Renal Tubular Necrosis, Hypoperfusion, Blood Creatinine Increased, Renal Failure Acute, Anuria

Adverse event resulted in: hospitalization

Suspect drug(s):
Altace
    Administration route: Oral
    End date: 2007-05-08

Lasilix / 00032601 /
    Administration route: Oral
    End date: 2007-05-08

Cordarone / 00133102 /
    Dosage: 200 mg, unk
    Administration route: Oral

Aldactone
    Administration route: Oral
    End date: 2007-05-08

Celebrex
    Administration route: Oral
    Indication: Pain in Extremity

Other drugs received by patient: Previscan / 00789001 /



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from Canada on 2007-03-06

Patient:

Adverse reactions / side effects: Dyspnoea, Loss of Consciousness, Fatigue, Throat Irritation, Insomnia, Chest Pain, Pharyngolaryngeal Pain, Dizziness, Bronchitis, Sinusitis, Cough

Adverse event resulted in: hospitalization

Suspect drug(s):
Altace (Ramipril)

Other drugs received by patient: Adalat; Crestor



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from France on 2007-02-05

Patient:

Adverse reactions / side effects: Pulmonary Hypertension, Right Ventricular Failure, Dyspnoea, Hypotension, Electromechanical Dissociation, Renal Failure, Cyanosis, Hypoxia, Hypertension, Shock, Venous Occlusion

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Altace
    Dosage: 10 mg, qd
    Administration route: Oral

Cozaar
    Dosage: 1 u, qd
    Administration route: Oral

Detensiel / 00802601 /
    Dosage: 10 mg, qd
    Administration route: Oral

Rapamune
    Dosage: 4 mg, qd
    Administration route: Oral
    End date: 2006-12-09

Lercan
    Dosage: 1 u, qd
    Administration route: Oral
    End date: 2006-12-09

Cellcept
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2005-07-16
    End date: 2006-12-09

Other drugs received by patient: Luteran

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009